# Allogeneic Blood Stem Cell Transplantation

> **NCT00423709** · NA · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 46 (actual)

## Conditions studied

- Hodgkin's Disease

## Interventions

- **PROCEDURE:** Allogeneic Blood Stem Cell Transplantation
- **DRUG:** Fludarabine
- **DRUG:** Melphalan

## Key facts

- **NCT ID:** NCT00423709
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-01
- **Primary completion:** 2007-08
- **Final completion:** 2007-08
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2012-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00423709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00423709, "Allogeneic Blood Stem Cell Transplantation". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00423709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*